STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines
Roche has inked a drug discovery deal with Chinese biotech Defand Therapeutics, focused on molecular glue medicines.
1 across the spectrum. Choose a side on the bar to jump to it.
2 articles from 1 source. Updated 7d ago.
Left
0 viewpointsNo Left coverage yet.
A blind spot on this side of the story.
Center
1 viewpointRight
0 viewpointsNo Right coverage yet.
A blind spot on this side of the story.